Search is Powered by Google
Follow us on:
Follow our health news on Twitter
Follow Our News on Facebook
Personalization
login | register
Melanoma / Skin Cancer News

Benefits of sunlight for human health

Main Category: Melanoma / Skin Cancer
Also Included In: Public Health;  Cancer / Oncology
Article Date: 22 Jun 2004 - 8:00 PDT

email icon email to a friend   printer icon printer friendly   write icon view / write opinions   rate icon rate article
Current Article Ratings:

Patient / Public:4 and a half stars

4.05 (21 votes)

Health Professional:4 and a half stars

4.09 (11 votes)

Article Opinions: 0 posts

While it is wise to avoid burning [Kennedy et al., 2003] or excess tanning from solar or indoor ultraviolet radiation (UVR), it should be realized that solar UVB radiation (290-315 nm) is the primary source of vitamin D for most Americans and Europeans. Dietary sources are inadequate and supplements have to be used carefully.

Mid-day summer sun is the best source of UVB, since minimal exposure times are required, and the UVB to UVA (315-400 nm) ratio is highest. If using sunscreen, it might be advisable to go into the sun for 10-15 minutes without sunscreen to generate a day's worth of vitamin D.

As for melanoma and other skin cancer, several points should be made. First, while UVR generates free radicals that can do some of the damage, dietary antioxidants and skin pigmentation are nature's way of fighting free radicals. A recent paper by Millen et al. [2004] reported that diets high in antioxidants and low in fats and alcohol can reduce the risk of melanoma by about 50%. Smoking is also a risk factor for non-melanoma skin cancer. Second, occupational exposure to UVR is associated with reduced risk of melanoma [Kennedy et al., 2003].

The health benefits of UVB through production of vitamin D are considerable, with more benefits being recognized at a rapid pace. My work indicates that over 20,000 Americans die prematurely annually from insufficient UVB/vitamin D [Grant, 2002]. I also estimate that half of those with multiple sclerosis in the U.S. would not have MS if they had as much UVB exposure as those living in the southern states.

For more information on the health benefits of UVB, please visit, http://www.sunarc.org.

References

Grant WB. An estimate of premature cancer mortality in the United States due to inadequate doses of solar ultraviolet-B radiation, Cancer. 2002;94:1867-75.

http://www3.interscience.wiley.com/cgi-bin/abstract/91016211/START (30 ISI citations) (note - this puts the paper in the top 1 percentile of clinical medicine papers published in 2002; threshold = 26 on May 1, 2004) http://www.in-cites.com/thresholds-highly-cited.html

Kennedy C, Bajdik CD, Willemze R, De Gruijl FR, Bouwes Bavinck JN; Leiden Skin Cancer Study. The influence of painful sunburns and lifetime sun exposure on the risk of actinic keratoses, seborrheic warts, melanocytic nevi, atypical nevi, and skin cancer. J Invest Dermatol. 2003 Jun;120(6):1087-93.

Millen AE, Tucker MA, Hartge P, Halpern A, Elder DE, Guerry D 4th, Holly EA, Sagebiel RW, Potischman N. Diet and melanoma in a case-control study. Cancer Epidemiol Biomarkers Prev. 2004 Jun;13(6):1042-51.

By William B. Grant Ph.D.




Personalized Homepage Weekly Newsletters Daily News Alerts
Hemophilia Opioid Induced Constipation Pneumococcal Disease ADHD Anxiety Asthma Atrial Fibrillation Autism Cancer Diabetes Lung Cancer Lupus Medicare / Medicaid Obesity and BMI Pancreatic Cancer Stem Cells All 'What Is...' Articles

Ophthalmology Urology
About Us News Licensing Free Website Feeds Free Tools & Content Tell a Friend Accessibility Help / FAQ Article Submission Links Contact Us

add medical news today to your facebook
medical news gadget

Please fill in our survey

Swine Flu Image

Swine Flu Updates

- Latest Swine Flu News
- What is Swine Flu?
- Map Of H1N1 Outbreaks
- Swine Flu - Top 20 FAQ
- Daily Email News Alerts
Stick with Medical News Today for the latest news updates on swine flu.


These are the most read articles from this news category for the last 6 months:
Top Article Star
Plexxikon Announces PLX4032 Phase 1 Data Showing Objective Responses In Metastatic Melanoma Patients
02 Jun 2009
Plexxikon Inc. today announced preliminary data from a Phase 1 clinical study investigating PLX4032 (R7204). PLX4032 is a novel, oral and highly selective drug that targets the BRAFV600E cancer-causing mutation that occurs...


Talking with Your Doctor image Talking with Your Doctor

Talking with your doctor can sometimes be difficult. Good health care, however, depends on an open dialogue between patients and doctors...

Talking with Your Doctor image Talking with Your Doctor

Talking with your doctor can sometimes be difficult. Good health care, however, depends on an open dialogue between patients and doctors...

View more videos...